Registry of Lobbyists
| Organization: | Cystic Fibrosis Canada/Fibrose kystique Canada |
| Associated registration: | 939590-266824-29 |
| Communication date: | 2024-02-05 |
| Posted date: | 2024-02-15 |
| Designated Public Office Holders who participated in the communication: |
Julie Dabrusin,
Member of Parliament
House of Commons Karen Reynolds, Director General Pharmaceutical Drugs Directorate, Health Products and Food Branch, Health Canada (HC) Jeffrey Skene, Director Health Products and Food Branch, Pharmaceutical Drugs Directorate, Bureau of Cardiology, Allergy and Neurological Sciences, Health Canada (HC) Andrew Taylor, Director, Policy, Research, and Data Strategic Policy Branch, Office of Pharmaceuticals Management Strategies, Health Canada (HC) Dan Albas, Member of Parliament House of Commons |
| Subject Matter of the communication: | Health |
| Responsible Officer who filed this communication report: | Kelly Grover |
| As the most senior paid officer, the person named above is responsible for certifying the communication report for the corporation or organization (Registrant). This person may or may not have participated in the reported communication. The Lobbyists Registration Regulations do not require that the names of in-house lobbyists (i.e. employees of corporations or organizations) who actually participated in the communication be disclosed. | |